Citation: Am. Karkar et al., Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-alpha, NEPH DIAL T, 16(3), 2001, pp. 518-524
Citation: R. Ghacha et al., HbA1c and serum fructosamine as markers of the chronic glycemic state in type 2 diabetic hemodialysis patients, DIALYSIS T, 30(4), 2001, pp. 214
Citation: R. Ghacha et al., A clinical and histological study in HCV-reactive hemodialysis patients asa pretransplant workup, DIALYSIS T, 30(1), 2001, pp. 15-18
Authors:
Tam, FWK
Smith, J
Agarwal, S
Karkar, AM
Morel, D
Thompson, EM
Pusey, CD
Citation: Fwk. Tam et al., Type IV phosphodiesterase inhibitor is effective in prevention and treatment of experimental crescentic glomerulonephritis, NEPHRON, 84(1), 2000, pp. 58-66
Authors:
Reynolds, J
Tam, FWK
Chandraker, A
Smith, J
Karkar, AM
Cross, J
Peach, R
Sayegh, MH
Pusey, CD
Citation: J. Reynolds et al., CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis (vol 105, pg 643, 2000), J CLIN INV, 105(7), 2000, pp. 1023-1023
Authors:
Reynolds, J
Tam, FWK
Chandraker, A
Smith, J
Karkar, AM
Cross, J
Peach, R
Sayegh, MH
Pusey, CD
Citation: J. Reynolds et al., CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis, J CLIN INV, 105(5), 2000, pp. 643-651
Authors:
Tam, FWK
Smith, J
Morel, D
Karkar, AM
Thompson, EM
Cook, HT
Pusey, CD
Citation: Fwk. Tam et al., Development of scarring and renal failure in a rat model of crescentic glomerulonephritis, NEPH DIAL T, 14(7), 1999, pp. 1658-1666